Consolidated Statements of Cash Flows (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Supplemental disclosures of non-cash transactions:
Patent costs accrued from Auxilium	$ 60,000
Patent amortization expenses	64,323	64,190	50,685
Decreased in deferred tax assets and additional paid in capital due to cancelation of stock options	$ 75,000
Stock options, cancelled (in shares)	15,000